InsiderClue
Insiders · Profile

Dexcel Pharma Technologies Ltd.

10% owner at Roivant Sciences · 10% owner at Protalix BioTherapeutics. Filing since 2 Jun 2021. CIK 0001720007

ROIV Roivant Sciences Ltd. 10% owner · 3 trades PLX Protalix BioTherapeutics, Inc. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ROIV Roivant Sciences Ltd.
10 Nov 2022
10% owner
Bought
4,000,000
$20.00M
4.0%
ROIV Roivant Sciences Ltd.
25 Apr 2022
10% owner
Bought
8,600
$33.64K
0.0%
ROIV Roivant Sciences Ltd.
22 Apr 2022
10% owner
Bought
31,685
$121.32K
0.0%
PLX Protalix BioTherapeutics, Inc.
3 Jun 2021
10% owner
Sold, plan not stated
857,506
$1.93M
19.1%
PLX Protalix BioTherapeutics, Inc.
2 Jun 2021
10% owner
Sold, plan not stated
61,211
$156.55K
1.3%
5 decisions on file.